CRB
Chad R. Baker Portfolio holdings
AUM
$538M
This Quarter Return
+7.2%
1 Year Return
+20.8%
3 Year Return
+87.18%
5 Year Return
+140.51%
10 Year Return
–
AUM
$509M
AUM Growth
+$509M
(+6.3%)
Cap. Flow
+$891K
Cap. Flow
% of AUM
0.17%
Top 10 Holdings %
Top 10 Hldgs %
45.87%
Holding
53
New
2
Increased
5
Reduced
9
Closed
3
Top Buys
| 1 |
UL Solutions
ULS
|
$2.9M |
| 2 |
Alcon
ALC
|
$2.85M |
| 3 |
RELX
RELX
|
$2.69M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$2.14M |
| 5 |
McCormick & Company Non-Voting
MKC
|
$404K |
Top Sells
| 1 |
WIRE
Encore Wire Corp
WIRE
|
$3.77M |
| 2 |
Apple
AAPL
|
$3.5M |
| 3 |
Canadian National Railway
CNI
|
$1.56M |
| 4 |
Fortive
FTV
|
$1.11M |
| 5 |
Carrier Global
CARR
|
$327K |
Sector Composition
| 1 | Technology | 32.4% |
| 2 | Industrials | 19.43% |
| 3 | Healthcare | 17.82% |
| 4 | Consumer Discretionary | 11.34% |
| 5 | Communication Services | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
New York Times
NYT
$9.55B
| $7.98M | 1.57% |
143,325
| – | – |
|
27
Cloudflare
NET
$72B
| $7.76M | 1.52% |
95,900
| – | – |
|
28
Lowe's Companies
LOW
$145B
| $7.61M | 1.5% |
28,100
| – | – |
|
29
TJX Companies
TJX
$154B
| $7.33M | 1.44% |
62,340
| – | – |
|
30
Home Depot
HD
$405B
| $7.15M | 1.4% |
17,635
| – | – |
|
31
Stryker
SYK
$148B
| $6.9M | 1.36% |
19,095
-50
| -0.3% | -$18.1K |
|
32
Colgate-Palmolive
CL
$68B
| $5.32M | 1.04% |
51,200
| – | – |
|
33
Zoetis
ZTS
$67.2B
| $4.85M | 0.95% |
24,818
| – | – |
|
34
CRISPR Therapeutics
CRSP
$4.76B
| $4.66M | 0.92% |
99,280
+760
| +0.8% | +$35.7K |
|
35
Adobe
ADBE
$146B
| $4.66M | 0.92% |
9,000
| – | – |
|
36
RTX Corp
RTX
$212B
| $4.65M | 0.91% |
38,348
| – | – |
|
|
37
Vertex Pharmaceuticals
VRTX
$102B
| $4.53M | 0.89% |
9,740
+4,595
| +89% | +$2.14M |
|
38
Alphabet (Google) Class C
GOOG
$2.53T
| $3.69M | 0.73% |
22,100
| – | – |
|
39
CSX Corp
CSX
$59.8B
| $3.52M | 0.69% |
102,000
| – | – |
|
|
40
UL Solutions
ULS
$12.8B
| $2.9M | 0.57% |
+58,800
| New | +$2.9M |
|
|
41
RELX
RELX
$82.9B
| $2.69M | 0.53% |
+56,775
| New | +$2.69M |
|
42
Merck
MRK
$212B
| $2.46M | 0.48% |
21,700
| – | – |
|
43
Cigna
CI
$80.4B
| $2.02M | 0.4% |
5,841
| – | – |
|
44
Exxon Mobil
XOM
$489B
| $1.92M | 0.38% |
16,400
| – | – |
|
|
45
McCormick & Company Non-Voting
MKC
$18.5B
| $1.29M | 0.25% |
15,625
+4,910
| +46% | +$404K |
|
46
NVIDIA
NVDA
$4.12T
| $1.28M | 0.25% |
10,500
-250
| -2% | -$30.4K |
|
47
Aptiv
APTV
$17B
| $1.07M | 0.21% |
14,845
| – | – |
|
48
Becton Dickinson
BDX
$54.1B
| $1.06M | 0.21% |
4,385
+1,365
| +45% | +$329K |
|
49
Pfizer
PFE
$141B
| $709K | 0.14% |
24,500
| – | – |
|
50
Novo Nordisk
NVO
$249B
| $617K | 0.12% |
5,180
-200
| -4% | -$23.8K |
|